Hollencrest Capital Management’s Quest Diagnostics DGX Stock Holding History

Hollencrest Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50	Closed	-$9.53K	–	1188
2025 Q3	$9.53K	Hold	50	–	–	﹤0.01%	805
2025 Q2	$8.98K	Hold	50	–	–	﹤0.01%	787
2025 Q1	$8.46K	Sell	50 -200	-80%	-$32.9K	﹤0.01%	795
2024 Q4	$37.7K	Sell	250 -184	-42%	-$28.6K	﹤0.01%	582
2024 Q3	$67.4K	Sell	434 -603	-58%	-$90.1K	﹤0.01%	461
2024 Q2	$142K	Hold	1,037	–	–	0.01%	334
2024 Q1	$138K	Buy	1,037 +28	+3%	+$3.63K	0.01%	314
2023 Q4	$139K	Hold	1,009	–	–	0.01%	326
2023 Q3	$123K	Hold	1,009	–	–	0.01%	337
2023 Q2	$142K	Sell	1,009 -1	-0.1%	-$138	0.01%	338
2023 Q1	$143K	Buy	1,010 +200	+25%	+$28.6K	0.02%	323
2022 Q4	$127K	Buy	+810	New	+$116K	0.02%	306

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hollencrest Capital Management's DGX Position: Q4 2025 in Review

Hollencrest Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 50 shares — an estimated $9.53K sold.

Hollencrest Capital Management first reported a position in DGX in Q4 2022 and held it in 12 quarters. The position peaked at $143K in Q1 2023. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Hollencrest Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Hollencrest Capital Management sold 50 Quest Diagnostics shares in Q4 2025, an estimated $9.53K.
Hollencrest Capital Management first reported a position in Quest Diagnostics in Q4 2022 and held it in 12 quarters.
Hollencrest Capital Management's Quest Diagnostics position peaked at $143K in Q1 2023.
1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.